相关实验视频

Updated: Jun 14, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

在LMIC中推进个性化医疗:宫癌免疫治疗反应的预测指标

Carla Eksteen¹, Johann Riedemann², Frederick H van der Merwe³

¹Department of Physiological Sciences, Faculty of Science, University of Stellenbosch, Stellenbosch, South Africa.

Seminars in oncology

|June 12, 2025

概括

预测性生物标志物对于有效的宫癌免疫治疗至关重要. 识别这些指标有助于选择可能响应的患者,改善治疗结果,特别是在资源较少的环境中.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
全球健康全球健康

背景情况:

子宫癌是全球主要的健康挑战,特别是在低收入和中等收入国家 (LMICs).
晚期子宫癌的治疗选择有限,这凸显了对新型治疗策略的需求.
免疫疗法显示出有希望的结果,但表现出患者反应的变化,需要预测生物标志物.

研究的目的:

审查目前用于宫癌免疫治疗的预测生物标志物.
确定影响宫癌患者免疫治疗疗效的因素.
强调在LMICs中需要精制生物标志物.

主要方法:

关于宫癌免疫治疗中的预测生物标志物的文献综述.
对免疫检查点分子,瘤突变负担和免疫细胞透的分析.
讨论其他因素,如细胞因子和先前的化疗暴露.

主要成果:

关键的预测生物标志物包括免疫检查点分子,瘤突变负担和免疫细胞透.
细胞因子,透瘤的淋巴细胞,以及之前的基于的化疗也是相关的因素.
目前的生物标志物需要精细化,以在宫癌免疫治疗中进行最佳患者选择.

结论:

预测生物标志物对于优化宫癌免疫疗法至关重要.
需要进一步的研究来完善这些生物标志物,特别是对于LMICs.
改善患者选择将提高免疫疗法疗效和宫癌的治疗结果.

关键词:

生物标志物生物标志物宫癌是发生在宫癌的原因之一.免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.小微创新型国家和地区 (LMIC)微观环境是一个微观环境.瘤透的淋巴细胞透到瘤中

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...